drugset / Trial / NCT06519968

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled AZD4604 in Healthy Japanese and Chinese Participants.

NCT06519968 ↗

Phase 1 Completed 56 enrolled AstraZeneca Parexel · collab
RandomizedSequentialDouble-blindTreatment

Summary

The purpose of this study is to investigate the safety, tolerability, and pharmacokinetics (PK) of AZD4604 when administered as single or multiple inhaled doses to healthy Japanese and Chinese participants.

Timeline

Start
2024-07-15
Primary completion
2024-12-27
Completion
2024-12-27

Drugs

EvaluationDrugModalityDoseRoute
Subject LONDAMOCITINIB Small molecule — Inhaled

Indications

No indication recorded.